Study of high sensitivity c-reactive protein (hs-crp) levels in early and late onset preEclampsia in a tertiary care hospital: A one-year cross-sectional study.

Abstract

Background: Pre eclampsia remains a significant cause of maternal and perinatal morbidity and mortality worldwide, with early onset preeclampsia often leading to more severe complications than late onset preeclampsia. Systemic inflammation plays a central role in the pathogenesis of preeclampsia. High-sensitivity C-reactive protein (hs-CRP), a sensitive inflammatory biomarker, has been proposed as a potential tool to assess disease severity and predict fetomaternal outcomes. Objective: To compare hs-CRP levels between early and late onset pre eclampsia and evaluate its association with maternal and fetal outcomes.